Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populations

Pharmacogenetics

Volumn 12, Issue 6, 2002, Pages 437-450

  Tang, Kun ^a   Ngoi, Soo Mun ^a   Gwee, Pai Chung ^a   Chua, John M Z ^a   Lee, Edmund J D ^a   Chong, Samuel S ^a   Lee, Caroline G L ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

ABCB1; Haplotype; Linkage disequilibrium; MDR1 gene; Single nucleotide polymorphism

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; DNA; PRIMER DNA;

5' UNTRANSLATED REGION; ALLELE; ARTICLE; ASIAN; CHINESE; CONTROLLED STUDY; ETHNIC GROUP; EXON; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; INDIAN; NEWBORN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; CHEMISTRY; CHINA; ETHNOLOGY; GENE; GENETIC MARKER; GENETICS; INDIA; INTRON; MALAYSIA; METABOLISM; POLYMERASE CHAIN REACTION; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGAPORE;

5' UNTRANSLATED REGIONS; ALLELES; CHINA; DNA; DNA PRIMERS; ETHNIC GROUPS; EXONS; GENE FREQUENCY; GENES, MDR; GENETIC MARKERS; GENOTYPE; HAPLOTYPES; HUMAN; INDIA; INTRONS; LINKAGE DISEQUILIBRIUM; MALAYSIA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SINGAPORE; HUMANS;

EID: 0036667956     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200208000-00004     Document Type: Article

References (47)

1. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter
2. HIV-1 protease inhibitors and the MDR1 multidrug transporter
3. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
4. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
5. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs
6. Contribution to substrate specificity and transport of nonconserved residues in transmembrane domain 12 of human P-glycoprotein
7. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters
8. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene
9. Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance
10. MDR1 pharmacogenetics: Frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
11. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
12. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells
13. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
14. Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects
15. ABC drug transporters: Hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
16. How to manage individualized drug therapy: Application of pharmacogenetic knowledge of drug metabolism and transport
17. Frequency of C3435T polymorphism of MDR1 gene in African people
18. Expression of P-glycoprotein in human placenta: Relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene
19. Identification of functionally variant MDR1 alleles among European Americans and African Americans
20. Pharmacogenetics of the human drug-transporter gene MDR1: Impact of polymorphisms on pharmacotherapy
21. Polymorphisms in the ABC drug transporter gene MDR1
22. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
23. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects
24. Pharmacokinetic differences between ethnic groups
25. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: A pharmacogenetic study
26. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients
27. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression
28. A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated with major depression
29. Genomic organization of the human multidrug resistance (MDR1) gene and origin of P-glycoproteins
30. A new polymorphism (N21D) in the exon 2 of the human MDR1 gene encoding the P-glycoprotein
31. Multidrug resistance during chemical carcinogenesis: A mechanism revealed?
32. Biochemistry of multidrug resistance mediated by the multidrug transporter
33. Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population
34. Linkage disequilibrium in the human genome
35. Allelic association with SNPs: Metrics, populations, and the linkage disequilibrium map
36. Molecular basis of ethnic differences in drug disposition and response
37. Polymorphisms in drug-metabolizing enzymes: What is their clinical relevance and why do they exist?
38. A DNA polymorphism discovery resource for research on human genetic variation
39. The role of single nucleotide polymorphisms (SNPs) in understanding complex disorders and pharmacogenomics
40. Pharmacogenetics and pharmacogenomics: Why is this relevant to the clinical geneticist?
41. Single-nucleotide polymorphisms can cause different structural folds of mRNA
42. RNA secondary structure: An important cis-element in rat calcitonin/CGRP pre-messenger RNA splicing
43. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes
44. Specificity of ribonucleoprotein interaction determined by RNA folding during complex formulation
45. The structure of an RNA pseudoknot that causes efficient frameshifting in mouse mammary tumor virus
46. Structure and dynamics of the iron responsive element RNA: Implications for binding of the RNA by iron regulatory binding proteins